Soligenix

Yahoo Finance • 20 days ago

IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.

AUSTIN, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of T... Full story

Yahoo Finance • 4 months ago

Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad

NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- via BioMedWire: — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (Investor... Full story

Yahoo Finance • 4 months ago

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

AUSTIN, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare system, with the National Insti... Full story

Yahoo Finance • 4 months ago

Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- via BioMedWire: — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (Investor... Full story

Yahoo Finance • 5 months ago

Soligenix GAAP EPS of -$0.58 beats by $0.05

* Soligenix press release [https://seekingalpha.com/pr/20298712-soligenix-announces-recent-accomplishments-and-third-quarter-2025-financial-results] (SNGX [https://seekingalpha.com/symbol/SNGX]): Q3 GAAP EPS of -$0.58 beats by $0.05. *... Full story

Yahoo Finance • 7 months ago

Soligenix files to sell 2.91M shares of common stock, 2.91M warrants

* Soligenix (NASDAQ:SNGX [https://seekingalpha.com/symbol/SNGX]) filed to sell 2.91M shares of common stock, 2.91M warrants. * Filing [https://seekingalpha.com/filing/10436085] MORE ON SOLIGENIX * Seeking Alpha’s Quant Rating on... Full story

Yahoo Finance • 8 months ago

Most active stocks in Monday's session

Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity. [mostactive] TOP MOST ACTIVE STOCKS TICKE... Full story

Yahoo Finance • 8 months ago

Form 8K Soligenix Inc For: 18 August

... Full story

Yahoo Finance • 8 months ago

Why Soligenix Is Rising In Pre-market?

(RTTNews) - Soligenix (SNGX) announced that the Office of Orphan Products Development of FDA has granted orphan drug designation to dusquetide, the active ingredient in SGX945, for treatment of Behçet's Disease following review of recent P... Full story

Yahoo Finance • 8 months ago

NetworkNewsAudio Announces Audio Press Release (APR) on Promising First-Line Therapy for Rare Skin Cancer

AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas,” featuring Soligenix Inc. (N... Full story

Yahoo Finance • 8 months ago

Unusual volume stocks in Monday's session

Unusual volume stocks are being observed in Monday's session. [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT PBM [https://www.chartmill.com/stock/quote/PBM/profile] 76.28% PSYENCE BIOMEDICAL LTD (NASDAQ:P... Full story

Yahoo Finance • 8 months ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Oriental Rise Holdings Ltd. 97,958,700 0.1452 0.1206 0.1264 +0.0166 Open... Full story

Yahoo Finance • 8 months ago

Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas

NetworkNewsWire Editorial Coverage NEW YORK, Aug. 4, 2025 /CNW/ -- As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that disproportionately affects older adults. With more than... Full story

Yahoo Finance • 8 months ago

Soligenix reports positive results from SGX945 Behçet's trial

PRINCETON, N.J. - Soligenix, Inc. (NASDAQ:SNGX) announced Thursday that its Phase 2a proof of concept study evaluating SGX945 (dusquetide) in the treatment of Behçet’s Disease has achieved its objective of demonstrating biological efficacy... Full story

Yahoo Finance • 10 months ago

Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases wher... Full story

Yahoo Finance • last year

IBN Initiates Coverage of Soligenix Inc.

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with an unmet medical need, has s... Full story

Yahoo Finance • 3 years ago

New to The Street TV Announces its 399th Show, Featuring Five Corporate Interviews, Airing on the Fox Business Network, Tonight, Monday, October 24, 2022, at 10:30 PM PT

NEW YORK, Oct. 24, 2022 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally syndicated TV show, announces episode #399 airing tonight, Monday, October 24, 2022, at 10:30 PM PT on the Fox Business Network. New to The Street’s... Full story

Yahoo Finance • 4 years ago

Presenting on the Emerging Growth Conference on August 17 Register Now

MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of... Full story

Yahoo Finance • 4 years ago

Celularity Appoints Industry Leader Diane Parks to its Board of Directors

FLORHAM PARK, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, today announced the appoint... Full story